Yu Kanemaru

Niigata, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.

Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.

Journal: Journal of neuro-oncology
Published: November 10, 2023

Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide.

Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide.

Journal: Cancers
Published: December 22, 2021

HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma.

HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 28, 2021

SWI by 7T MR Imaging for the Microscopic Imaging Diagnosis of Astrocytic and Oligodendroglial Tumors.

SWI by 7T MR Imaging for the Microscopic Imaging Diagnosis of Astrocytic and Oligodendroglial Tumors.

Journal: AJNR. American journal of neuroradiology
Published: October 14, 2021

Elucidating the multiple genetic alterations involved in the malignant transformation of a KRAS mutant neurenteric cyst. A case report.

Elucidating the multiple genetic alterations involved in the malignant transformation of a KRAS mutant neurenteric cyst. A case report.

Journal: Neuropathology : official journal of the Japanese Society of Neuropathology
Published: September 17, 2021

Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features.

Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features.

Journal: Brain tumor pathology
Published: June 13, 2021

Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.

Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.

Journal: Diagnostics (Basel, Switzerland)
Published: March 02, 2021

Less-invasive diagnosis of disseminated epithelioid glioblastoma harboring BRAF V600E mutation by cerebrospinal fluid analysis-A case report.

Less-invasive diagnosis of disseminated epithelioid glioblastoma harboring BRAF V600E mutation by cerebrospinal fluid analysis-A case report.

Journal: Clinical case reports
Published: February 05, 2021

GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma.

GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma.

Journal: Journal of neuropathology and experimental neurology
Published: November 29, 2020

High Detection Rate of MYD88 Mutations in Cerebrospinal Fluid From Patients With CNS Lymphomas.

High Detection Rate of MYD88 Mutations in Cerebrospinal Fluid From Patients With CNS Lymphomas.

Journal: JCO precision oncology
Published: December 01, 2019

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas.

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas.

Journal: Frontiers in oncology
Published: October 02, 2019

Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma.

Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma.

Journal: Leukemia & lymphoma
Published: July 16, 2019
Showing 1-12 of 18

Last Updated: 09/26/2026